Deepak Nitrite Q1 Review - Increased Emphasis On Downstream Products To Boost Growth: Systematix

A lab technician prepares samples at the laboratory. (Photographer: Paul O'Driscoll/Bloomberg News)

Deepak Nitrite Q1 Review - Increased Emphasis On Downstream Products To Boost Growth: Systematix

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Systematix Research Report

Deepak Nitrite Ltd.’s Q1 FY22 results were slightly above our estimates with sales/Ebitda/adjusted profit after tax growth of 4%/down 1%/4% QoQ, led by the performance chemicals (8% QoQ) and phenolics (7% QoQ) divisions that benefitted from a 31%/8%/24% QoQ increase in the prices of di-amino stilbene disulphate acid/optical brightening agents/phenol.

The sales of basic chemicals (up 2% QoQ) and fine and specialty chemicals (flat) were wedged due to lockdowns and logistics-related challenges.

Deepak Nitrite's operating profit margin was 29.6% versus 31.1% QoQ (estimate of 29.1%) due to margin pressures in the fine and specialty and performance chemicals divisions as raw material and freight costs remained elevated.

Click on the attachment to read the full report:

Systematix Deepak Nitrite Q1FY22.pdf


This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.